Afuco™ Anti-Human MICA ADCC Therapeutic Antibody (IPH43), ADCC Enhanced
Anti-MICA ADCC Enhanced Antibody (IPH43) is an ADCC enhanced antibody produced by our Afuco™ platform. IPH43 is a program to develop a first-in-class anti-MICA therapeutic antibody in oncology. MICA is a highly polymorphic ligand of the NK cell activating receptor NKG2D. MICA is specifically expressed on several highly prevalent solid tumors including breast, colorectal and lung.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-505CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | MICA |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |